UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009531
Receipt number R000011187
Scientific Title Study on treatment after complete resection of high risk gastrointestinal stromal tumor (GIST)
Date of disclosure of the study information 2012/12/13
Last modified on 2022/06/20 14:38:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on treatment after complete resection of high risk gastrointestinal stromal tumor (GIST)

Acronym

STAR ReGISTry

Scientific Title

Study on treatment after complete resection of high risk gastrointestinal stromal tumor (GIST)

Scientific Title:Acronym

STAR ReGISTry

Region

Japan


Condition

Condition

Gastrointestinal stromal tumor

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

The purpose of this study is to register patients who have undergone a curative resection (R0/R1 resection) in an initial gastrointestinal stromal tumor (GIST) and have been found to have high risk based on the modified-Fletcher Classification (Joensuu) and to study conditions and prognosis of their post surgical treatments. This study also covers an exploration of appropriate imatinib treatment period.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Recurrence-free survival

Key secondary outcomes

-Overall survival
-Occurrence and severity of adverse events
-Completion of treatment


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) The diagnosis of GIST is confirmed by KIT-positive of resected specimen or acquiring of genetic mutations with c-kit and PDGFRA
2) The subject is classified as high risk based on the modified-Fletcher Classification (Joensuu)
3) In initial GIST, a complete gross resection had been conducted and the resection is within 3 years prior to registration (if recurrence is found at the time, the registration shall be permitted when above condition is met.)
4) Over 20 years old
5) Patients are able to provide written informed consent, if the patient died at the time of registration, a consent must be obtained from the legal representative of the person

(Unless it has been six months or more after the surgery)
6) After the surgery, a periodic imaging test (every 6 months) has been conducted to examine possibility of recurrence

Key exclusion criteria

1) In case the patient has other serious illnesses other than GIST (other cancer, cardiovascular disease, brain disease, and hepatorenal diseases etc).
2) Resection of metastases/ disseminated lesion was concluded in initial GIST, a complete gross resection
3) In case the physician determines that participation in the study is not appropriate.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Toshirou
Middle name
Last name Nishida

Organization

National Cancer Center Hospital

Division name

Department of Surgery

Zip code

104-0045

Address

5-1-1 Tsukiji, Chuoku, Tokyo 104-0045, Japan

TEL

03-3542-2511

Email

tnishida@ncc.go.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Nakagawa

Organization

Translational Research Center for Medical Innovation

Division name

None

Zip code

650-0047

Address

1-5-4 Minatojima-minamimachi, Chuo-ku, Kobe, Japan 650-0047

TEL

078-303-9093

Homepage URL

http://www.tri-kobe.org/

Email

s-nakagawa@tri-kobe.org


Sponsor or person

Institute

The Research Group for Rare Neoplasms of Japan

Institute

Department

Personal name



Funding Source

Organization

Novartis Pharma K.K.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center

Address

5-1-1 Tsukiji, Chuoku, Tokyo 104-0045, Japan

Tel

03-3542-2511

Email

tnishida@ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人 国立がん研究センター 中央病院(東京都)
国立研究開発法人  国立がん研究センター 東病院(千葉県)
大阪警察病院(大阪府)
大阪大学医学部付属病院(大阪府)


Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 11 Month 07 Day

Date of IRB

2012 Year 11 Month 07 Day

Anticipated trial start date

2012 Year 12 Month 25 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 03 Month 31 Day

Date trial data considered complete

2020 Year 09 Month 30 Day

Date analysis concluded

2021 Year 10 Month 31 Day


Other

Other related information

prospective non-interventional study


Management information

Registered date

2012 Year 12 Month 12 Day

Last modified on

2022 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011187


Research Plan
Registered date File name
2022/06/20 【STAR ReGISTry】プロトコル_1.4版(案)clean版.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name